Pharmaceutical Industry

SENTISS AG 

Uster · Since 2013

Sentiss Pharma is a pharmaceutical company specializing in the development and manufacture of medicines, particularly in the field of ophthalmology and special products. The company's core activity includes research and development of new medicines, production of high-quality products, and provision of health solutions for customers worldwide. In contrast, Inzox is a financial services provider specializing in providing financial solutions for companies and private individuals. The company's core activity includes providing financial advisory services, managing assets, and providing financial products.

Servier (Suisse) SA 

Geneva · Since 1978

Servier (Suisse) SA is a subsidiary of the Servier Group that promotes and distributes medicines and provides information and support to healthcare professionals. The company works across therapeutic areas including oncology, cardiometabolic diseases, depression and venous disorders, offers a range of prescription medicines and does not sell products online or operate manufacturing/laboratory sites.

SGI Pharmaceuticals AG 

Zug · Since 2021

The core activity of SGI Pharmaceuticals AG is the development, manufacture and distribution of pharmaceutical products, particularly in emerging markets. The company focuses on providing high-quality medicines and services to improve access to healthcare in these regions. This also includes logistics and distribution services, such as storage, transportation and compliance with quality and safety standards.

Uriach Switzerland AG 

Rheinfelden · Since 1990

The core activity of Sidroga is the development, manufacture and marketing of medicinal teas, wellness teas and herbal teas, particularly for self-medication for various health problems such as colds, gastrointestinal diseases, sleep disorders and others.

SIEGFRIED DiNAMIQS AG 

Schlieren · Since 2020

SIEGFRIED DiNAMIQS AG is a CDMO for advanced medicine providing GMP‑compatible manufacturing and scalable production of viral vectors. The company focuses on AAV manufacturing and development for viral therapeutics and originated as a spin‑out from DiNAQOR before being scaled through a majority‑stake transaction with Siegfried.

Sincopharm S.A. 

Moudon · Since 1989

The core activity of Sincopharm is the development, manufacturing, and packaging of cosmetic products. This includes: Research and development (R&D) of individual and exclusive formulations for cosmetic products; Manufacturing of cosmetic products in various galenics (emulsions, gels, balms, lotions, etc.) in compliance with "Good Manufacturing Practices" (GMP) according to ISO 22716; Packaging of cosmetic products with a special machine that allows vacuum filling and ensures optimal quality; Consulting and support in the selection of packaging and in the regulation of cosmetic products. Overall, Sincopharm offers a comprehensive range of services for the development, manufacturing, and packaging of cosmetic products that meet the high standards of Swiss quality.

Skinpulse SARL 

Geneva · Since 1994

Skinpulse SARL is a specialized dermatology centre providing medical and aesthetic dermatology services. Offerings include dermatological check-ups, phototherapy, Mohs micrographic surgery and dermatologic surgery, laser treatments, injectables (hyaluronic acid, botulinum toxin), tattoo removal, body-shaping procedures and chemical peels; the clinical team comprises FMH-certified dermatologists with various subspecialties.

Skyhawk Therapeutics Europe GmbH 

Basel · Since 2018

The core activity of Skyhawk Therapeutics is the development of small molecules that modify RNA expression, particularly for the treatment of diseases in the areas of neurology, oncology and fibrosis. The company uses its own SKYSTAR platform to identify and develop RNA targets, and works with various pharmaceutical companies in this process.

S. L. A. Pharma AG 

Basel · Since 2018

The core activity of SLA Pharma is the development of solutions for gastrointestinal diseases, particularly in the development of medications and treatments for GI disorders such as anal fissure, pilonidal sinus and colorectal medicine. The company focuses on clinical development and collaborates with international partners to develop innovative solutions for complex gastrointestinal diseases.

SLC Bellevue GmbH 

Zurich · Since 2013

The core activity of SLC Bellevue GmbH - LUXES COSMETICS is the development, manufacture and marketing of natural cosmetics products, particularly skin care products, under the LUXES brand.

Somagenetix AG 

Altendorf · Since 2019

The core activity of Somagenetix AG is the development and research of gene therapies for genetic diseases, particularly for phagocytic disorders such as chronic granulomatous disease (CGD). The company focuses on the development of lentivirus-mediated gene therapies that are designed to offer a unique combination of safety, specificity and long-term efficacy.

Sonasenz GmbH 

Wichtrach · Since 2024

Sonasenz GmbH distributes Chlorella Dr. Ray dietary supplements and operates the associated online shop. The product range includes cold-ultramicroized liquid Chlorella vulgaris with selenium and the website provides ordering, shipping and returns information.

SOTIO Biotech AG 

Basel · Since 2019

The core activity of SOTIO is the development and research of oncological therapies, particularly in the field of biologics, such as antibody-drug conjugates (ADCs), immunocytokines and cell therapies. The company focuses on the development of drugs for the treatment of cancer and has built a pipeline of oncological programs driven by strategic licensing, M&A and internal discovery efforts.

Space Pharmaceuticals AG 

Bern · Since 2018

Space Pharmaceuticals AG provides CRDMO services for peptide research, development and manufacturing, including peptide discovery, custom synthesis and GMP peptide production. The company also offers process and analytical development, preclinical/clinical support and a portfolio of generic peptide APIs.

STALICLA SA 

Geneva · Since 2017

STALICLA SA is a biopharmaceutical company developing precision medicines and clinical programs for neurodevelopmental and neuropsychiatric disorders. It uses the DEPI neuro-precision platform, combining multi-omics, patient data and AI to identify subgroups and match patients with drug treatments.

Stallergenes Greer International AG 

Baar · Since 2013

The core activity of Stallergenes Greer is the development, manufacture and marketing of products for allergology and specifically for allergen immunotherapy (AIT). The company is a world leader in allergen and AIT products and has a significant global presence.

Stamm and Friends GmbH 

Riehen · Since 2005

The company is active in the pharmaceutical industry, specifically in the field of generics. The core activity includes searching for new developments, technologies and documentation for medicinal products, identifying and qualifying manufacturers, negotiating contracts and marketing generics and other pharmaceutical products. The company has an international network and has offices in Switzerland and China.

Stämm Vegh SA 

Monthey · Since 2023

Stämm Vegh SA develops solutions for biomanufacturing, bioengineering and bio‑AI to support biologics and cell therapy production and cell line development. Its offerings include a plug‑and‑play continuous bioreactor (the Bioprocessor) with a bubble‑free bioreactor, automated cell‑line engineering and clone‑selection platforms, and MoNA™ — a transomics platform for multi‑omic analysis and in‑silico cell simulation.

steinberg pharma ag 

Winterthur · Since 2008

The core activity of Steinberg Pharma AG is the development, production and distribution of complementary medical products, pharmaceuticals, medical devices, products for the podology specialist trade, as well as dietary supplements. In addition, the company offers services in the areas of registration, dossier maintenance and consulting.

Stiftung der Novartis AG für Erziehung, Ausbildung und Bildung 

Basel · Since 1973